A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.

[1]  D. Valla,et al.  Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[2]  J. Bosch,et al.  Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease , 2017, Hepatology.

[3]  Marta Hernández,et al.  Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease , 2017, Journal of gastroenterology and hepatology.

[4]  A. Ponte,et al.  The Baveno VI criteria for predicting esophageal varices: validation in real life practice. , 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[5]  A. Berzigotti.  Non-invasive evaluation of portal hypertension using ultrasound elastography. , 2017, Journal of hepatology.

[6]  G. Garcia‐Tsao,et al.  Validating, deconstructing and refining Baveno criteria for ruling out high‐risk varices in patients with compensated cirrhosis , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[7]  A. Schoepfer,et al.  Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[8]  Ioan Sporea,et al.  EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) , 2017, Ultraschall in der Medizin - European Journal of Ultrasound.

[9]  C. Strassburg,et al.  Shear‐wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[10]  J. Genescà,et al.  Validating the Baveno VI recommendations for screening varices. , 2017, Journal of hepatology.

[11]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[12]  J. Bosch,et al.  Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study , 2016, Hepatology.

[13]  M. Silva,et al.  Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Are We There Yet? , 2016, GE - Portuguese Journal of Gastroenterology.

[14]  Qiang Zhu,et al.  Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis , 2016, PloS one.

[15]  M. Pinzani,et al.  Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. , 2016, Journal of hepatology.

[16]  J. Trebicka,et al.  Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease , 2016, Gut.

[17]  L. Eusebi,et al.  Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature , 2015, European journal of gastroenterology & hepatology.

[18]  Asociacion Latinoamericana para el Estudio del Higado.  EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. , 2015, Journal of hepatology.

[19]  C. Radu,et al.  Non‐invasive ménage à trois for the prediction of high‐risk varices: stepwise algorithm using lok score, liver and spleen stiffness , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[20]  J. Talwalkar,et al.  Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: systematic review and meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  G. Casazza,et al.  Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. , 2014, Journal of hepatology.

[22]  G. D’Amico,et al.  Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients , 2014, Alimentary pharmacology & therapeutics.

[23]  J. Bosch,et al.  Use of noninvasive markers of portal hypertension and timing of screening endoscopy for gastroesophageal varices in patients with chronic liver disease , 2013, Hepatology.

[24]  Peter Schlattmann,et al.  Use of 3×2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies , 2012, BMJ : British Medical Journal.

[25]  G. Casazza,et al.  Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. , 2012, Gastroenterology.

[26]  J. Bosch,et al.  Non invasive evaluation of portal hypertension using transient elastography. , 2012, Journal of hepatology.

[27]  Radu Badea,et al.  Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients , 2011, Journal of gastroenterology and hepatology.

[28]  A. Sanyal,et al.  Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.

[29]  Ramon Planas,et al.  Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. , 2007, Gastroenterology.

[30]  Giacomo Belli,et al.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.

[31]  M. Merli,et al.  Incidence and natural history of small esophageal varices in cirrhotic patients. , 2003, Journal of hepatology.

[32]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[33]  D. Budescu.  Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression. , 1993 .

[34]  R. Groszmann,et al.  Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. , 1992, Journal of hepatology.

[35]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[36]  R. Groszmann,et al.  Portal pressure, presence of gastroesophageal varices and variceal bleeding , 1985, Hepatology.

[37]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[38]  K. Nouso,et al.  Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. , 2013, Gastroenterology.

[39]  L. Castéra,et al.  When the spleen gets tough, the varices get going. , 2013, Gastroenterology.

[40]  N. Mattek,et al.  Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. , 2007, Gastrointestinal endoscopy.

[41]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.